Equity Overview
Price & Market Data
Price: $0.0₃3
Daily Change: +$0.0₃1 / 33.33%
Range: $0.0₃2 - $0.0₃3
Market Cap: $219,584
Volume: 26,071,075
Performance Metrics
1 Week: -33.33%
1 Month: %
3 Months: -20.00%
6 Months: -80.00%
1 Year: -92.31%
YTD: -50.00%
Details
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.